News on haematological malignancies
First-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic…
The Menarini Group (“Menarini”), announced important new data on selinexor at the European Hematology Association (EHA) Congress 2023.…
In the early 1980s, City of Hope patient Paul Edmonds went to a bar in…
Chemotherapy has been the most effective treatment to date for young and fit patients with…
A new clinical tool developed by a team of researchers led by the Dana-Farber Cancer…
An international coalition of biomedical researchers co-led by Alexander Bick, MD, PhD, at Vanderbilt University Medical…
Tisch Cancer Center scientists developed unique models of the deadliest blood cancer, acute myeloid leukaemia…
Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH)…
A new nuclear medicine therapy can cure human non-Hodgkin lymphoma in an animal model, according…
A landmark discovery linking iron regulation to a rare blood cancer has led to clinical…